The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...

The sabotage of cellular messaging, triggered by the formation of chronic stress granules in the brain, may be a key factor ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...

Neurofibrillary tangles (NFTs) are a hallmark of Alzheimer’s disease, formed by the accumulation of tau protein into ...

Researchers say CSF biomarker test correlates with the severity of cognitive decline, independent of other factors, including brain amyloid deposition.

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the University of Pittsburgh School of Medicine can detect small amounts of the ...

Recent studies reveal how the timing of dreams may offer clues to Alzheimer's risk. How sleep patterns impact cognitive health and prevention.

The project specifically focused on the hippocampus, a region of the brain that's not only crucial for memory but also ...

Jan. 15, 2025 — Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a ...

Years before tau tangles show up in brain scans of patients with Alzheimer's disease, a biomarker test developed at the ...